ConductScience.org, home

Paper462379

A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.

Balch CM and 4 others. Surgery, 1979. Cited by 286 papers, by iCite.

Cite this record

ConductScience Library. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Papers, record 462379. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/462379

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
PubMed
Journal
Surgery
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
286
iCite
Relative citation ratio, by iCite
14.4
iCite
Revised in PubMed
2006-11-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Balch CMC M
2Soong SJS J
3Murad TMT M
4Ingalls ALA L
5Maddox WAW A

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Adult
Age Factors
Aged
Computers
Factor Analysis, Statistical
Female
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Organ Specificity
Prognosis
Regression Analysis
Sex Factors
Skin
Time Factors

Source PubMed

Download CSV of topics

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 286 citations.

PMIDTitleJournalYearIn PapersSource
33880571Phenotypic Characteristics and Melanoma Thickness in Women.Acta Derm Venereol2021https://conductscience.org/library/papers/33880571PubMed
30190904Lymph node dissection for melanoma: where do we stand?Melanoma Manag2017https://conductscience.org/library/papers/30190904PubMed
28181494Microenvironment-derived factors driving metastatic plasticity in melanoma.Nat Commun2017https://conductscience.org/library/papers/28181494PubMed
24531700
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.
Ann Surg Oncol2014https://conductscience.org/library/papers/24531700PubMed
23838920Age as a prognostic factor in patients with localized melanoma and regional metastases.Ann Surg Oncol2013https://conductscience.org/library/papers/23838920PubMed
23325294Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result.JAMA Surg2013https://conductscience.org/library/papers/23325294PubMed
23316408Primary malignant melanoma of the rectum: report of two cases.Case Rep Surg2012https://conductscience.org/library/papers/23316408PubMed
20512942Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.J Surg Oncol2010https://conductscience.org/library/papers/20512942PubMed
20379784Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.Ann Surg Oncol2010https://conductscience.org/library/papers/20379784PubMed
20183437Parametric modeling of localized melanoma prognosis and outcome.J Biopharm Stat2009https://conductscience.org/library/papers/20183437PubMed
18749293General surgery-important advances in clinical medicine: cutaneous melanoma.West J Med1983https://conductscience.org/library/papers/18749293PubMed
16633005Gender-related differences in outcome for melanoma patients.Ann Surg2006https://conductscience.org/library/papers/16633005PubMed
15895193Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up.World J Surg2005https://conductscience.org/library/papers/15895193PubMed
8813254Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.Ann Surg1996https://conductscience.org/library/papers/8813254PubMed
8554382Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method.Arch Dermatol Res1995https://conductscience.org/library/papers/8554382PubMed
8409692Anorectal malignant melanoma has a poor prognosis.Int J Colorectal Dis1993https://conductscience.org/library/papers/8409692PubMed
7748038Melanoma recurrence surveillance. Patient or physician based?Ann Surg1995https://conductscience.org/library/papers/7748038PubMed
7436592Selective surgical management of cutaneous melanoma of the head and neck.Ann Surg1980https://conductscience.org/library/papers/7436592PubMed
7247529Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.Ann Surg1981https://conductscience.org/library/papers/7247529PubMed
7212806A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease.Ann Surg1981https://conductscience.org/library/papers/7212806PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/462379

GET https://conductscience.org/api/papers/v1/462379/cited_by?page=2